USPTO 2015–2025 USPTO PatentsView US Corporation

CVS Pharmacy, Inc.

USPTO PatentsView assignee record - 122 granted patents across 26 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

RSS updates for this company

The verdict

According to USPTO PatentsView, CVS ranks #3,091 of 49,997 tracked US assignees by granted-patent volume, with 122 patents across 26 technology areas.

#3,091
of 49,997 US assignees by volume
Top 9%
by Innovation Score (53.4/100)
11.0
avg claims per patent
+33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3091 · US Corporation #3,091 · 122 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 122 grants
  • TOP-DECILE #3,091/49,997
  • PHOTO-FINISH Anker Innovations…
  • CPC-FOCUS G16H · 26 areas
  • INNOV-PAR 53.4/100
  • CLAIMS-PAR 11.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anker Innovations Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How CVS’s 53.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around CVS

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows CVS's Innovation Score is 53.4/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for CVS?

Each dot is one of CVS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). CVS’s own 11.0 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

CVS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 121.5122122.5123123.5 0510152025 Granted patents (volume) Avg claims / patent W.R. Grace & Co.-Conn. - 123, 18.04W R Grace & -ConnARM IP Limited - 122, 17.39ARM IPAnker Innovations Technology Co., Ltd. - 122, 3.03Anker Innovations…Beijing University OF Posts AND Telecommunications - 122, 12.4Beijing Universit…Ecco Sko A/S - 122, 7.02Ecco Sko A/SEwha UNIVERSITY—INDUSTRY Collaboration Foundation - 122, 11.25Ewha University—I…Early Warning Services, LLC - 122, 18.58Early Warning Ser…Forma Therapeutics, Inc. - 122, 22.9Forma TherapeuticsCVS Pharmacy, Inc. - 122, 10.99CVS Pharmacy
CVS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where CVS's grants concentrate

CVS Pharmacy, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 27.9% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (29 grants) versus a trough of 3 in 2016. By volume, CVS sits between W.R. Grace & Co.-Conn. and Forma Therapeutics, Inc..

CVS's three-year grant acceleration

From 2019–2021 to 2022–2024, CVS Pharmacy, Inc. moved from 28 to 51 grants (1.82x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #261. See the growth leaderboard.

Who files at CVS's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CVS holds 122 patents at rank #3,091, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CVS

By rank, the assignees closest to #3,091 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in CVS's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CVS, neither rank-band nor same-CPC leaders (those blocks stay above). In G16H (Healthcare Informatics), CVS ranks #139 of 3,149 assignees by patent count in that subclass.

CVS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 2016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
CVS Pharmacy, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 3 2.5%
2017 16 13.1%
2018 14 11.5%
2019 15 12.3%
2020 5 4.1%
2021 8 6.6%
2022 7 5.7%
2023 15 12.3%
2024 29 23.8%
2025partial year 10 8.2%

Which technologies does CVS Pharmacy, Inc. patent most?

Top 15 of 26 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CVS Pharmacy, Inc.'s patent record in context - here's where to go next.

  • CVS Pharmacy, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 27.9% of its portfolio - see every assignee active in that class. Explore G16H
  • Ranked #3,091 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CVS Pharmacy, Inc. against W.R. Grace & Co.-Conn., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.